ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Influenza Drugs - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-12P3311
Home | Market Reports | Health| Pharmacy
Global Influenza Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Influenza Drugs - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-12P3311
Report
November 2023
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Astrazeneca plc
Eli Lilly
Roche
GlaxoSmithKline PLC
Novartis
Pfizer Inc
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen

Influenza Drugs - Market Size

The global Influenza Drugs market size is expected to reach US$ 2151.5 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029.

Influenza Drugs - Market

Influenza Drugs - Market

The market is mainly driven by the significant applications of Influenza Drugs in various end use industries. The expanding demands from the Adults and Chidren, are propelling Influenza Drugs market. Zanamivir, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oseltamivir Phosphate segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Influenza Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Drugs covered in this report include Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc.
The global Influenza Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen

Scope of Influenza Drugs - Market Report

Report Metric Details
Report Name Influenza Drugs - Market
Forecasted market size in 2029 US$ 2151.5 million
CAGR 3.3%
Forecasted years 2023 - 2029
Global Influenza Drugs market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Drugs market, Segment by Type:
  • Zanamivir
  • Oseltamivir Phosphate
  • Peramivir
  • Other Influenza Drugs
Global Influenza Drugs market, by Application
  • Adults
  • Chidren
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Influenza Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Influenza Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Influenza Drugs - Market size in 2029?

Ans: The Influenza Drugs - Market size in 2029 will be US$ 2151.5 million.

What are the Application segmentation covered in the Influenza Drugs - Market report?

Ans: The Applications covered in the Influenza Drugs - Market report are Adults, Chidren

What are the Type segmentation covered in the Influenza Drugs - Market report?

Ans: The Types covered in the Influenza Drugs - Market report are Zanamivir, Oseltamivir Phosphate, Peramivir, Other Influenza Drugs

1 Influenza Drugs Market Overview
1.1 Influenza Drugs Product Overview
1.2 Influenza Drugs Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir Phosphate
1.2.3 Peramivir
1.2.4 Other Influenza Drugs
1.3 Global Influenza Drugs Market Size by Type
1.3.1 Global Influenza Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Influenza Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Influenza Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Influenza Drugs Sales Breakdown by Type (2018-2023)
2 Global Influenza Drugs Market Competition by Company
2.1 Global Top Players by Influenza Drugs Sales (2018-2023)
2.2 Global Top Players by Influenza Drugs Revenue (2018-2023)
2.3 Global Top Players by Influenza Drugs Price (2018-2023)
2.4 Global Top Manufacturers Influenza Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Drugs Market Competitive Situation and Trends
2.5.1 Influenza Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Drugs Market
2.8 Key Manufacturers Influenza Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Drugs Status and Outlook by Region
3.1 Global Influenza Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Influenza Drugs Historic Market Size by Region
3.2.1 Global Influenza Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Influenza Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Influenza Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Influenza Drugs Forecasted Market Size by Region
3.3.1 Global Influenza Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Influenza Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Influenza Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Influenza Drugs by Application
4.1 Influenza Drugs Market Segment by Application
4.1.1 Adults
4.1.2 Chidren
4.2 Global Influenza Drugs Market Size by Application
4.2.1 Global Influenza Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Influenza Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Influenza Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Influenza Drugs Sales Breakdown by Application (2018-2023)
5 North America Influenza Drugs by Country
5.1 North America Influenza Drugs Historic Market Size by Country
5.1.1 North America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Influenza Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Influenza Drugs Sales in Value by Country (2018-2023)
5.2 North America Influenza Drugs Forecasted Market Size by Country
5.2.1 North America Influenza Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Influenza Drugs Sales in Value by Country (2024-2029)
6 Europe Influenza Drugs by Country
6.1 Europe Influenza Drugs Historic Market Size by Country
6.1.1 Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Influenza Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Influenza Drugs Sales in Value by Country (2018-2023)
6.2 Europe Influenza Drugs Forecasted Market Size by Country
6.2.1 Europe Influenza Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Influenza Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Influenza Drugs by Region
7.1 Asia-Pacific Influenza Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Influenza Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Influenza Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Influenza Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Influenza Drugs Sales in Value by Region (2024-2029)
8 Latin America Influenza Drugs by Country
8.1 Latin America Influenza Drugs Historic Market Size by Country
8.1.1 Latin America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Influenza Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Influenza Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Influenza Drugs Forecasted Market Size by Country
8.2.1 Latin America Influenza Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Influenza Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Influenza Drugs by Country
9.1 Middle East and Africa Influenza Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Influenza Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Influenza Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Influenza Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Influenza Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb]
10.1.1 Bristol-Myers Squibb] Company Information
10.1.2 Bristol-Myers Squibb] Introduction and Business Overview
10.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
10.1.5 Bristol-Myers Squibb] Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Influenza Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly Influenza Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche Influenza Drugs Products Offered
10.4.5 Roche Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKline Influenza Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Influenza Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Influenza Drugs Products Offered
10.7.5 Pfizer Recent Development
10.8 Sanofi Pasteur
10.8.1 Sanofi Pasteur Company Information
10.8.2 Sanofi Pasteur Introduction and Business Overview
10.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Pasteur Influenza Drugs Products Offered
10.8.5 Sanofi Pasteur Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Influenza Drugs Products Offered
10.9.5 Bayer Recent Development
10.10 Celgene
10.10.1 Celgene Company Information
10.10.2 Celgene Introduction and Business Overview
10.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Celgene Influenza Drugs Products Offered
10.10.5 Celgene Recent Development
10.11 Seqirus
10.11.1 Seqirus Company Information
10.11.2 Seqirus Introduction and Business Overview
10.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Seqirus Influenza Drugs Products Offered
10.11.5 Seqirus Recent Development
10.12 Protein Sciences Corporation
10.12.1 Protein Sciences Corporation Company Information
10.12.2 Protein Sciences Corporation Introduction and Business Overview
10.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Protein Sciences Corporation Influenza Drugs Products Offered
10.12.5 Protein Sciences Corporation Recent Development
10.13 Serum Institute of India
10.13.1 Serum Institute of India Company Information
10.13.2 Serum Institute of India Introduction and Business Overview
10.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Serum Institute of India Influenza Drugs Products Offered
10.13.5 Serum Institute of India Recent Development
10.14 Emergent Biosolutions
10.14.1 Emergent Biosolutions Company Information
10.14.2 Emergent Biosolutions Introduction and Business Overview
10.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Emergent Biosolutions Influenza Drugs Products Offered
10.14.5 Emergent Biosolutions Recent Development
10.15 BioCryst Pharmaceuticals
10.15.1 BioCryst Pharmaceuticals Company Information
10.15.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BioCryst Pharmaceuticals Influenza Drugs Products Offered
10.15.5 BioCryst Pharmaceuticals Recent Development
10.16 Alvogen
10.16.1 Alvogen Company Information
10.16.2 Alvogen Introduction and Business Overview
10.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Alvogen Influenza Drugs Products Offered
10.16.5 Alvogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Drugs Industrial Chain Analysis
11.4 Influenza Drugs Market Dynamics
11.4.1 Influenza Drugs Industry Trends
11.4.2 Influenza Drugs Market Drivers
11.4.3 Influenza Drugs Market Challenges
11.4.4 Influenza Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Drugs Distributors
12.3 Influenza Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Astrazeneca plc
Eli Lilly
Roche
GlaxoSmithKline PLC
Novartis
Pfizer Inc
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
List of Tables
    Table 1. Major Company of Zanamivir
    Table 2. Major Company of Oseltamivir Phosphate
    Table 3. Major Company of Peramivir
    Table 4. Major Company of Other Influenza Drugs
    Table 5. Global Influenza Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Influenza Drugs Sales by Type (2018-2023) & (K MT)
    Table 7. Global Influenza Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 8. Global Influenza Drugs Sales by Type (2018-2023) & (US& Million)
    Table 9. Global Influenza Drugs Market Share in Value by Type (2018-2023)
    Table 10. Global Influenza Drugs Price by Type (2018-2023) & (USD/MT)
    Table 11. Global Influenza Drugs Sales by Type (2024-2029) & (K MT)
    Table 12. Global Influenza Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 13. Global Influenza Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 14. Global Influenza Drugs Sales Market Share in Value by Type (2024-2029)
    Table 15. Global Influenza Drugs Price by Type (2024-2029) & (USD/MT)
    Table 16. North America Influenza Drugs Sales by Type (2018-2023) & (K MT)
    Table 17. North America Influenza Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 18. Europe Influenza Drugs Sales (K MT) by Type (2018-2023)
    Table 19. Europe Influenza Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 20. Asia-Pacific Influenza Drugs Sales (K MT) by Type (2018-2023)
    Table 21. Asia-Pacific Influenza Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 22. Latin America Influenza Drugs Sales (K MT) by Type (2018-2023)
    Table 23. Latin America Influenza Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 24. Middle East and Africa Influenza Drugs Sales (K MT) by Type (2018-2023)
    Table 25. Middle East and Africa Influenza Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 26. Global Influenza Drugs Sales by Company (2018-2023) & (K MT)
    Table 27. Global Influenza Drugs Sales Share by Company (2018-2023)
    Table 28. Global Influenza Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 29. Global Influenza Drugs Revenue Share by Company (2018-2023)
    Table 30. Global Market Influenza Drugs Price by Company (2018-2023) & (USD/MT)
    Table 31. Global Influenza Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 32. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
    Table 34. Date of Key Manufacturers Enter into Influenza Drugs Market
    Table 35. Key Manufacturers Influenza Drugs Product Type
    Table 36. Mergers & Acquisitions, Expansion Plans
    Table 37. Global Influenza Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Global Influenza Drugs Sales by Region (2018-2023) & (K MT)
    Table 39. Global Influenza Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 40. Global Influenza Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 41. Global Influenza Drugs Sales Market Share in Value by Region (2018-2023)
    Table 42. Global Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 43. Global Influenza Drugs Sales by Region (2024-2029) & (K MT)
    Table 44. Global Influenza Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 45. Global Influenza Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 46. Global Influenza Drugs Sales Market Share in Value by Region (2024-2029)
    Table 47. Global Influenza Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
    Table 48. Global Influenza Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 49. Global Influenza Drugs Sales by Application (2018-2023) & (K MT)
    Table 50. Global Influenza Drugs Sales Market Share in Volume by Application (2018-2023)
    Table 51. Global Influenza Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 52. Global Influenza Drugs Sales Market Share in Value by Application (2018-2023)
    Table 53. Global Influenza Drugs Price by Application (2018-2023) & (USD/MT)
    Table 54. Global Influenza Drugs Sales by Application (2024-2029) & (K MT)
    Table 55. Global Influenza Drugs Sales Market Share in Volume by Application (2024-2029)
    Table 56. Global Influenza Drugs Sales by Application (2024-2029) & (US$ Million)
    Table 57. Global Influenza Drugs Sales Market Share in Value by Application (2024-2029)
    Table 58. Global Influenza Drugs Price by Application (2024-2029) & (USD/MT)
    Table 59. North America Influenza Drugs Sales by Application (2018-2023) (K MT)
    Table 60. North America Influenza Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 61. Europe Influenza Drugs Sales by Application (2018-2023) (K MT)
    Table 62. Europe Influenza Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 63. Asia-Pacific Influenza Drugs Sales by Application (2018-2023) (K MT)
    Table 64. Asia-Pacific Influenza Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 65. Latin America Influenza Drugs Sales by Application (2018-2023) (K MT)
    Table 66. Latin America Influenza Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 67. Middle East and Africa Influenza Drugs Sales by Application (2018-2023) (K MT)
    Table 68. Middle East and Africa Influenza Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 69. North America Influenza Drugs Sales by Country (2018-2023) & (K MT)
    Table 70. North America Influenza Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 71. North America Influenza Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 72. North America Influenza Drugs Sales Market Share in Value by Country (2018-2023)
    Table 73. North America Influenza Drugs Sales by Country (2024-2029) & (K MT)
    Table 74. North America Influenza Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 75. North America Influenza Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 76. North America Influenza Drugs Sales Market Share in Value by Country (2024-2029)
    Table 77. Europe Influenza Drugs Sales by Country (2018-2023) & (K MT)
    Table 78. Europe Influenza Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 79. Europe Influenza Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 80. Europe Influenza Drugs Sales Market Share in Value by Country (2018-2023)
    Table 81. Europe Influenza Drugs Sales by Country (2024-2029) & (K MT)
    Table 82. Europe Influenza Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 83. Europe Influenza Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 84. Europe Influenza Drugs Sales Market Share in Value by Country (2024-2029)
    Table 85. Asia-Pacific Influenza Drugs Sales by Region (2018-2023) & (K MT)
    Table 86. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 87. Asia-Pacific Influenza Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 88. Asia-Pacific Influenza Drugs Sales Market Share in Value by Region (2018-2023)
    Table 89. Asia-Pacific Influenza Drugs Sales by Region (2024-2029) & (K MT)
    Table 90. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 91. Asia-Pacific Influenza Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 92. Asia-Pacific Influenza Drugs Sales Market Share in Value by Region (2024-2029)
    Table 93. Latin America Influenza Drugs Sales by Country (2018-2023) & (K MT)
    Table 94. Latin America Influenza Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 95. Latin America Influenza Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 96. Latin America Influenza Drugs Sales Market Share in Value by Country (2018-2023)
    Table 97. Latin America Influenza Drugs Sales by Country (2024-2029) & (K MT)
    Table 98. Latin America Influenza Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 99. Latin America Influenza Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 100. Latin America Influenza Drugs Sales Market Share in Value by Country (2024-2029)
    Table 101. Middle East and Africa Influenza Drugs Sales by Country (2018-2023) & (K MT)
    Table 102. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 103. Middle East and Africa Influenza Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 104. Middle East and Africa Influenza Drugs Sales Market Share in Value by Country (2018-2023)
    Table 105. Middle East and Africa Influenza Drugs Sales by Country (2024-2029) & (K MT)
    Table 106. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 107. Middle East and Africa Influenza Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 108. Middle East and Africa Influenza Drugs Sales Market Share in Value by Country (2024-2029)
    Table 109. Bristol-Myers Squibb] Company Information
    Table 110. Bristol-Myers Squibb] Introduction and Business Overview
    Table 111. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 112. Bristol-Myers Squibb] Influenza Drugs Product
    Table 113. Bristol-Myers Squibb] Recent Development
    Table 114. AstraZeneca Company Information
    Table 115. AstraZeneca Introduction and Business Overview
    Table 116. AstraZeneca Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 117. AstraZeneca Influenza Drugs Product
    Table 118. AstraZeneca Recent Development
    Table 119. Eli Lilly Company Information
    Table 120. Eli Lilly Introduction and Business Overview
    Table 121. Eli Lilly Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 122. Eli Lilly Influenza Drugs Product
    Table 123. Eli Lilly Recent Development
    Table 124. Roche Company Information
    Table 125. Roche Introduction and Business Overview
    Table 126. Roche Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 127. Roche Influenza Drugs Product
    Table 128. Roche Recent Development
    Table 129. GlaxoSmithKline Company Information
    Table 130. GlaxoSmithKline Introduction and Business Overview
    Table 131. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 132. GlaxoSmithKline Influenza Drugs Product
    Table 133. GlaxoSmithKline Recent Development
    Table 134. Novartis Company Information
    Table 135. Novartis Introduction and Business Overview
    Table 136. Novartis Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 137. Novartis Influenza Drugs Product
    Table 138. Novartis Recent Development
    Table 139. Pfizer Company Information
    Table 140. Pfizer Introduction and Business Overview
    Table 141. Pfizer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 142. Pfizer Influenza Drugs Product
    Table 143. Pfizer Recent Development
    Table 144. Sanofi Pasteur Company Information
    Table 145. Sanofi Pasteur Introduction and Business Overview
    Table 146. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 147. Sanofi Pasteur Influenza Drugs Product
    Table 148. Sanofi Pasteur Recent Development
    Table 149. Bayer Company Information
    Table 150. Bayer Introduction and Business Overview
    Table 151. Bayer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 152. Bayer Influenza Drugs Product
    Table 153. Bayer Recent Development
    Table 154. Celgene Company Information
    Table 155. Celgene Introduction and Business Overview
    Table 156. Celgene Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 157. Celgene Influenza Drugs Product
    Table 158. Celgene Recent Development
    Table 159. Seqirus Company Information
    Table 160. Seqirus Introduction and Business Overview
    Table 161. Seqirus Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 162. Seqirus Influenza Drugs Product
    Table 163. Seqirus Recent Development
    Table 164. Protein Sciences Corporation Company Information
    Table 165. Protein Sciences Corporation Introduction and Business Overview
    Table 166. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 167. Protein Sciences Corporation Influenza Drugs Product
    Table 168. Protein Sciences Corporation Recent Development
    Table 169. Serum Institute of India Company Information
    Table 170. Serum Institute of India Introduction and Business Overview
    Table 171. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 172. Serum Institute of India Influenza Drugs Product
    Table 173. Serum Institute of India Recent Development
    Table 174. Emergent Biosolutions Company Information
    Table 175. Emergent Biosolutions Introduction and Business Overview
    Table 176. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 177. Emergent Biosolutions Influenza Drugs Product
    Table 178. Emergent Biosolutions Recent Development
    Table 179. BioCryst Pharmaceuticals Company Information
    Table 180. BioCryst Pharmaceuticals Introduction and Business Overview
    Table 181. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 182. BioCryst Pharmaceuticals Influenza Drugs Product
    Table 183. BioCryst Pharmaceuticals Recent Development
    Table 184. Alvogen Company Information
    Table 185. Alvogen Introduction and Business Overview
    Table 186. Alvogen Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 187. Alvogen Influenza Drugs Product
    Table 188. Alvogen Recent Development
    Table 189. Key Raw Materials Lists
    Table 190. Raw Materials Key Suppliers Lists
    Table 191. Influenza Drugs Market Trends
    Table 192. Influenza Drugs Market Drivers
    Table 193. Influenza Drugs Market Challenges
    Table 194. Influenza Drugs Market Restraints
    Table 195. Influenza Drugs Distributors List
    Table 196. Influenza Drugs Downstream Customers
    Table 197. Research Programs/Design for This Report
    Table 198. Key Data Information from Secondary Sources
    Table 199. Key Data Information from Primary Sources
List of Figures
    Figure 1. Influenza Drugs Product Picture
    Figure 2. Global Influenza Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Influenza Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Influenza Drugs Sales Status and Outlook (2018-2029) & (K MT)
    Figure 5. Product Picture of Zanamivir
    Figure 6. Global Zanamivir Sales YoY Growth (2018-2029) & (K MT)
    Figure 7. Product Picture of Oseltamivir Phosphate
    Figure 8. Global Oseltamivir Phosphate Sales YoY Growth (2018-2029) & (K MT)
    Figure 9. Product Picture of Peramivir
    Figure 10. Global Peramivir Sales YoY Growth (2018-2029) & (K MT)
    Figure 11. Product Picture of Other Influenza Drugs
    Figure 12. Global Other Influenza Drugs Sales YoY Growth (2018-2029) & (K MT)
    Figure 13. Global Influenza Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 14. Global Influenza Drugs Sales Market Share by Type in 2022 & 2029
    Figure 15. North America Influenza Drugs Sales Market Share in Volume by Type in 2022
    Figure 16. North America Influenza Drugs Sales Market Share in Value by Type in 2022
    Figure 17. Europe Influenza Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. Europe Influenza Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Asia-Pacific Influenza Drugs Sales Market Share in Value by Type in 2022
    Figure 21. Latin America Influenza Drugs Sales Market Share in Volume by Type in 2022
    Figure 22. Latin America Influenza Drugs Sales Market Share in Value by Type in 2022
    Figure 23. Middle East and Africa Influenza Drugs Sales Market Share in Volume by Type in 2022
    Figure 24. Middle East and Africa Influenza Drugs Sales Market Share in Value by Type in 2022
    Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs Sales in 2022
    Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Drugs Revenue in 2022
    Figure 27. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 28. Product Picture of Adults
    Figure 29. Global Adults Sales YoY Growth (2018-2029) & (K MT)
    Figure 30. Product Picture of Chidren
    Figure 31. Global Chidren Sales YoY Growth (2018-2029) & (K MT)
    Figure 32. Global Influenza Drugs Sales by Application (2018-2029) & (US$ Million)
    Figure 33. Global Influenza Drugs Sales Market Share by Application in 2022 & 2029
    Figure 34. North America Influenza Drugs Sales Market Share in Volume by Application in 2022
    Figure 35. North America Influenza Drugs Sales Market Share in Value by Application in 2022
    Figure 36. Europe Influenza Drugs Sales Market Share in Volume by Application in 2022
    Figure 37. Europe Influenza Drugs Sales Market Share in Value by Application in 2022
    Figure 38. Asia-Pacific Influenza Drugs Sales Market Share in Volume by Application in 2022
    Figure 39. Asia-Pacific Influenza Drugs Sales Market Share in Value by Application in 2022
    Figure 40. Latin America Influenza Drugs Sales Market Share in Volume by Application in 2022
    Figure 41. Latin America Influenza Drugs Sales Market Share in Value by Application in 2022
    Figure 42. Middle East and Africa Influenza Drugs Sales Market Share in Value by Application in 2022
    Figure 43. Key Raw Materials Price
    Figure 44. Influenza Drugs Manufacturing Cost Structure
    Figure 45. Influenza Drugs Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36H8345
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34R905
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2R9930
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34L14446
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions